Bio Protocol vs Harvest Finance — how do they compare? Bio Protocol trades at Rp516.61 (market cap Rp1,15T, Rp264,79M 24h volume), while Harvest Finance trades at Rp103,810 (market cap Rp92,33M, Rp17,88M 24h volume). The key difference: Bio Protocol is far larger — about 12455.3× Harvest Finance's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Harvest Finance's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Harvest Finance for 46 Days on average.
| BIO | FARM | |
|---|---|---|
Market Cap | Rp1,15T | Rp92,33M |
Volume (24h) | Rp264,79M | Rp17,88M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 672,2K FARM |
Typical Hold Time | 16 Days | 46 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Harvest Finance (FARM) shows a market cap of Rp92.33 million with a circulating supply of 672.2k tokens, indicating a relatively small-cap DeFi asset. The average hold time of 46 days suggests moderate investor retention. Current trading activity appears limited based on available metrics, with no major protocol upgrades or ecosystem developments reported in recent crypto-specific channels.
Outlook remains cautious due to limited trading activity and small market size. Key opportunity lies in potential DeFi protocol revivals, while major risks include low liquidity and high volatility typical of small-cap tokens. Investors should monitor for any protocol updates or exchange listings that could impact price discovery.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Harvest Finance is an asset management platform that seeks to maximize yield for assets deposited into Harvest vaults. The protocols vaults execute various yield farming strategies; the profits from these strategies are split between liquidity providers and rewarding users staked in their profit-sharing pool.
Read more on FARM →